News summary

Physical activity in preclinical Alzheimer disease: current evidence and implications for multimodal longitudinal research

Source: Frontiers - Health • Published: 16 Oct 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Physical activity and wearable-measured behaviors are examined as repeatable research signals in studies of preclinical Alzheimer disease, with guidance for longitudinal multimodal designs aimed at linking behavior to biomarkers and cognitive trajectories.

Physical activity in preclinical Alzheimer disease: current evidence and implications for multimodal longitudinal research
Key Takeaways
  • Objective wearable measures of physical activity, gait, and rest-activity are repeatable, inexpensive research signals but are not specific biomarkers for Alzheimer disease.
  • Higher baseline step counts in biomarker-characterized cohorts have been associated with slower tau accumulation and slower cognitive and functional decline.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.